Evidence map›Paper›PMID 16283248›Full record

ArticleDiabetologia2005

Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.

S L Longnus, C Ségalen, J Giudicelli, M P Sajan, R V Farese, E Van Obberghen

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Hypoglycemic effects of brassinosteroid in diet-induced obese mice.American journal of physiology. Endocrinology and metabolism · 2012
    Article
  10. Article
  11. Review
  12. Article
  13. AKT signalling in the failing heart.European journal of heart failure · 2011
    Review
  14. Regulation of AMPK by the ubiquitin proteasome system.The American journal of pathology · 2011
    Review
  15. Article
  16. Article
  17. AMPK exerts dual regulatory effects on the PI3K pathway.Journal of molecular signaling · 2010
    Article
  18. Short-term regulation of organic anion transporters.Pharmacology & therapeutics · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

S L LongnusINSERM U145, IFR 50, Faculty of Medicine, Avenue de Valombrose, 06107,, Nice Cedex 2, France. vanobbeg@unice.fr
C Ségalen
J Giudicelli
M P Sajan
R V Farese
E Van Obberghen
Inserm · FRFlorida College · USUniversity of South Florida · US

Funding

Activation of Atypical PKC by Insulin and Other AgonistsR01DK065969 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI FARESE, ROBERT V · 2004 to 2014
$2.8M
NIDDK NIH HHS R01 DK065969NIDDK NIH HHS R01-DK065969-01A1
6 · The paper itself

Abstract

aims/hypothesis5'AMP-activated protein kinase (AMPK) and insulin stimulate glucose transport in heart and muscle. AMPK acts in an additive manner with insulin to increase glucose uptake, thereby suggesting that AMPK activation may be a useful strategy for ameliorating glucose uptake, especially in cases of insulin resistance. In order to characterise interactions between the insulin- and AMPK-signalling pathways, we investigated the effects of AMPK activation on insulin signalling in the rat heart in vivo.

methodsMale rats (350-400 g) were injected with 1 g/kg 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) or 250 mg/kg metformin in order to activate AMPK. Rats were administered insulin 30 min later and after another 30 min their hearts were removed. The activities and phosphorylation levels of components of the insulin-signalling pathway were subsequently analysed in individual rat hearts.

resultsAICAR and metformin administration activated AMPK and enhanced insulin signalling downstream of protein kinase B in rat hearts in vivo. Insulin-induced phosphorylation of glycogen synthase kinase 3 (GSK3) beta, p70 S6 kinase (p70S6K)(Thr389) and IRS1(Ser636/639) were significantly increased following AMPK activation. To the best of our knowledge, this is the first report of heightened insulin responses of GSK3beta and p70S6K following AMPK activation. In addition, we found that AMPK inhibits insulin stimulation of IRS1-associated phosphatidylinositol 3-kinase activity, and that AMPK activates atypical protein kinase C and extracellular signal-regulated kinase in the heart. CONCLUSIONS/INTERPRETATIONS: Our data are indicative of differential effects of AMPK on the activation of components in the cardiac insulin-signalling pathway. These intriguing observations are critical for characterisation of the crosstalk between AMPK and insulin signalling.

Indexed as

Aminoimidazole CarboxamideAMP-Activated Protein KinasesAnimalsBlood GlucoseEnzyme ActivationGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHeartInsulinInsulin Receptor Substrate ProteinsMaleMetforminMitogen-Activated Protein Kinase 3Multienzyme ComplexesMyocardiumPhosphatidylinositol 3-KinasesAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesBlood GlucoseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, ratInsulinInsulin Receptor Substrate ProteinsIrs1 protein, ratMetforminMitogen-Activated Protein Kinase 3Multienzyme ComplexesPhosphatidylinositol 3-KinasesPhosphoproteinsProtein Kinase CProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktRibonucleotidesRibosomal Protein S6 Kinases, 70-kDa

Identifiers

PMID16283248
OpenAlexW1986364902

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.